食用ワクチンの世界市場レポート 2025年

食用ワクチン市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は9.2％で、136億3,000万米ドルに成長します。予測期間中の成長は、パンデミック対策に対する需要の高まり、植物バイオテクノロジーの進歩、遺伝子組み換え食品に対する社会的認識と受容の高まり、コールドチェーンの課題への対応、食糧安全保障の取り組みとの統合などに起因すると考えられます。予測期間における主な動向には、動物衛生分野への拡大、バイオファーミングの利用拡大、個別化栄養とワクチン接種、持続可能性と環境に配慮したワクチン、多抗原食用ワクチンの開発などがあります。

感染症の流行の増加が、今後数年間の食用ワクチン市場の成長を牽引すると予想されます。感染症は、細菌、ウイルス、真菌、寄生虫などの有害な微生物が体内に侵入し、増殖することによって引き起こされる病気です。感染症の増加は、グローバリゼーション、気候変動、都市化、抗生物質耐性といった、新たな病原体の拡散や出現を促進する要因によるところが大きいです。食用ワクチンは、抗原を産生する遺伝子組み換え食品を摂取することで免疫反応を刺激し、費用対効果が高く注射針を使わない予防接種法を提供することで、感染症と闘うための解決策を提供します。例えば2024年3月、米国の公衆衛生機関である疾病対策予防センター（CDC）は、結核患者数が2022年の8,320人から2023年には9,615人へと1,295人増加したと報告しました。さらに、人口10万人当たりの罹患率は、2022年の2.5から2023年には2.9に上昇しました。したがって、感染症の流行が拡大していることは、食用ワクチン市場の重要な促進要因となっています。

食用ワクチン市場の主な企業は、世界のコレラ危機に対処するため、経口コレラワクチン（OCV）などの革新的ソリューションの開発に注力しています。OCVは、コレラ菌によって引き起こされる重篤な下痢性疾患であるコレラを予防するために経口投与されるワクチンです。例えば、2024年8月、インドのバイオテクノロジー企業Bharat Biotech International Limitedが、いくつかの有利な特徴を持つ経口コレラ・ワクチンHillcholを発売しました。この弱毒化ワクチンは、全身性免疫反応と粘膜免疫反応の両方を誘導し、コレラに対する防御を提供します。ヒルコールの特筆すべき点は、投与が容易であることと、冷蔵保存が不要であることで、資源が限られた環境での使用に適しています。さらに、1回の投与で長期間にわたって免疫力が持続します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界食用ワクチンPESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の食用ワクチン市場：成長率分析
• 世界の食用ワクチン市場の実績：規模と成長, 2019-2024
• 世界の食用ワクチン市場の予測：規模と成長, 2024-2029, 2034F
• 世界食用ワクチン総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の食用ワクチン市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 不活化ワクチン
• サブユニットワクチン
• デオキシリボ核酸（DNA）ワクチン
• 生弱毒化ワクチン
• その他のタイプ
• 世界の食用ワクチン市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 獣医クリニック
• 小売薬局
• オンライン薬局
• 世界の食用ワクチン市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 医療
• 家畜
• 養殖業
• 農業
• その他の用途
• 世界の食用ワクチン市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 大人
• 小児科
• 動物
• 世界の食用ワクチン市場不活化ワクチンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 全不活化ウイルスワクチン
• 不活化細菌ワクチン
• 世界の食用ワクチン市場サブユニットワクチンの種類別細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• タンパク質サブユニットワクチン
• 多糖サブユニットワクチン
• 世界の食用ワクチン市場デオキシリボ核酸（DNA）ワクチンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• プラスミドDNAワクチン
• 合成DNAワクチン
• 世界の食用ワクチン市場生弱毒化ワクチンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 生弱毒化ウイルスワクチン
• 生弱毒化細菌ワクチン
• 世界の食用ワクチン市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ウイルス様粒子（VLP）ワクチン
• mRNAワクチン

第7章 地域別・国別分析

• 世界の食用ワクチン市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の食用ワクチン市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 食用ワクチン市場：競合情勢
• 食用ワクチン市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • GSK plc Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• C.H. Boehringer Sohn AG & Co. KG
• Novavax Inc.
• Ceva Sante Animale
• Sinovac Biotech Ltd.
• Hualan Biological Engineering Inc.
• Zydus Lifesciences Limited
• Bharat Biotech International Limited
• Medicago Inc.
• CureVac N.V.
• Profectus BioSciences Inc.
• Vaxart Inc.
• China National Biotec Group Company Limited
• Vaxine Pty Ltd.
• Vaxiion Therapeutics Inc.
• Therapix Biosciences Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 食用ワクチン市場2029：新たな機会を提供する国
• 食用ワクチン市場2029：新たな機会を提供するセグメント
• 食用ワクチン市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

An edible vaccine is a type of vaccine developed in genetically modified plants or animals, designed to be delivered through consumption rather than injection. These vaccines stimulate an immune response when an edible plant or food, such as fruits or vegetables, is consumed. This concept aims to provide a cost-effective and easily accessible alternative to traditional vaccines, particularly in developing countries.

The primary types of edible vaccines include inactivated vaccines, subunit vaccines, deoxyribonucleic acid (DNA) vaccines, live attenuated vaccines, and others. Inactivated vaccines are made from viruses or bacteria that have been killed or inactivated so they cannot cause disease, yet still elicit an immune response, such as the polio and hepatitis A vaccines. Distribution channels for these vaccines encompass hospitals, veterinary clinics, retail pharmacies, and online pharmacies. Their applications span medical care, livestock, aquaculture, agriculture, and more. Edible vaccines are utilized by a diverse range of end users, including adults, pediatric populations, and animals.

The edible vaccine market research report is one of a series of new reports from The Business Research Company that provides edible vaccine market statistics, including edible vaccine industry global market size, regional shares, competitors with a edible vaccine market share, detailed edible vaccine market segments, market trends and opportunities, and any further data you may need to thrive in the edible vaccine industry. This edible vaccine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The edible vaccine market size has grown strongly in recent years. It will grow from $8.77 billion in 2024 to $9.6 billion in 2025 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to advancements in genetic engineering, challenges with traditional vaccines, advances in biopharming, growing focus on global immunization, and increasing funding and support from governments.

The edible vaccine market size is expected to see strong growth in the next few years. It will grow to $13.63 billion in 2029 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to the growing demand for pandemic preparedness, advancements in plant biotechnology, growing public awareness and acceptance of genetically modified foods, addressing cold chain challenges, and integration with food security initiatives. Major trends in the forecast period include expansion into animal health, increased use of biopharming, personalized nutrition and vaccination, sustainability and green vaccines, and the development of multi-antigen edible vaccines.

The increasing prevalence of infectious diseases is anticipated to drive the growth of the edible vaccine market in the coming years. Infectious diseases are illnesses caused by harmful microorganisms, including bacteria, viruses, fungi, or parasites, that invade the body and multiply. The rise in infectious diseases is largely attributed to factors such as globalization, climate change, urbanization, and antibiotic resistance, which facilitate the spread and emergence of new pathogens. Edible vaccines offer a solution for combating infectious diseases by stimulating immune responses through the consumption of genetically modified foods that produce antigens, providing a cost-effective and needle-free immunization method. For instance, in March 2024, the Centers for Disease Control and Prevention (CDC), a U.S.-based public health agency, reported that the number of tuberculosis cases increased from 8,320 in 2022 to 9,615 in 2023, marking a rise of 1,295 cases. Additionally, the incidence rate per 100,000 people rose from 2.5 in 2022 to 2.9 in 2023. Therefore, the escalating prevalence of infectious diseases is a significant driver of the edible vaccine market.

Key companies in the edible vaccine market are concentrating on developing innovative solutions, such as oral cholera vaccines (OCVs), to address the global cholera crisis. OCVs are vaccines administered orally to prevent cholera, a severe diarrheal disease caused by the bacterium Vibrio cholerae. For example, in August 2024, Bharat Biotech International Limited, an India-based biotechnology company, launched Hillchol, an oral cholera vaccine with several advantageous features. This live-attenuated vaccine induces both systemic and mucosal immune responses, offering protection against cholera. Hillchol is notable for its ease of administration and the fact that it does not require cold storage, making it suitable for use in resource-limited settings. Additionally, it provides long-lasting immunity with just a single dose.

In May 2022, Ceva Sante Animale, a France-based pharmaceutical company, acquired Artemis Technologies Inc. for an undisclosed amount. This acquisition aims to strengthen Ceva Sante Animale's oral rabies vaccine portfolio and expand its presence in wildlife disease management. Artemis Technologies Inc. is a Canada-based company specializing in the provision of oral rabies vaccines.

Major companies operating in the edible vaccine market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., GSK plc, C.H. Boehringer Sohn AG & Co. KG, Novavax Inc., Ceva Sante Animale, Sinovac Biotech Ltd., Hualan Biological Engineering Inc., Zydus Lifesciences Limited, Bharat Biotech International Limited, Medicago Inc., CureVac N.V., Profectus BioSciences Inc., Vaxart Inc., China National Biotec Group Company Limited, Vaxine Pty Ltd., Vaxiion Therapeutics Inc., Therapix Biosciences Ltd., Mymetics Corporation

North America was the largest region in the edible vaccine market in 2023. The regions covered in the edible vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the edible vaccine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The edible vaccine market consists of sales of plant-based edible vaccines, animal-based edible vaccines, algae-based edible vaccines, and yeast-based edible vaccines. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Edible Vaccine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on edible vaccine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for edible vaccine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The edible vaccine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Inactivated Vaccines; Subunit Vaccines; Deoxyribonucleic Acid (DNA) Vaccines; Live Attenuated Vaccines; Other Types
• 2) By Distribution Channel: Hospitals; Veterinary Clinics; Retail Pharmacies; Online Pharmacies
• 3) By Application: Medical Care; Livestock; Aquaculture; Agriculture; Other Applications
• 4) By End User: Adults; Pediatrics; Animals
• Subsegments:
• 1) By Inactivated Vaccines: Whole Inactivated Virus Vaccines; Inactivated Bacterial Vaccines
• 2) By Subunit Vaccines: Protein Subunit Vaccines; Polysaccharide Subunit Vaccines
• 3) By Deoxyribonucleic Acid (DNA) Vaccines: Plasmid DNA Vaccines; Synthetic DNA Vaccines
• 4) By Live Attenuated Vaccines: Live Attenuated Viral Vaccines; Live Attenuated Bacterial Vaccines
• 5) By Other Types: Virus-Like Particle (VLP) Vaccines; mRNA Vaccines
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Merck & Co. Inc.; Sanofi S.A.; GSK plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Edible Vaccine Market Characteristics

3. Edible Vaccine Market Trends And Strategies

4. Edible Vaccine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Edible Vaccine Growth Analysis And Strategic Analysis Framework

• 5.1. Global Edible Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Edible Vaccine Market Growth Rate Analysis
• 5.4. Global Edible Vaccine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Edible Vaccine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Edible Vaccine Total Addressable Market (TAM)

6. Edible Vaccine Market Segmentation

• 6.1. Global Edible Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Inactivated Vaccines
• Subunit Vaccines
• Deoxyribonucleic Acid (DNA) Vaccines
• Live Attenuated Vaccines
• Other Types
• 6.2. Global Edible Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Veterinary Clinics
• Retail Pharmacies
• Online Pharmacies
• 6.3. Global Edible Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medical Care
• Livestock
• Aquaculture
• Agriculture
• Other Applications
• 6.4. Global Edible Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Adults
• Pediatrics
• Animals
• 6.5. Global Edible Vaccine Market, Sub-Segmentation Of Inactivated Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Whole Inactivated Virus Vaccines
• Inactivated Bacterial Vaccines
• 6.6. Global Edible Vaccine Market, Sub-Segmentation Of Subunit Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Protein Subunit Vaccines
• Polysaccharide Subunit Vaccines
• 6.7. Global Edible Vaccine Market, Sub-Segmentation Of Deoxyribonucleic Acid (DNA) Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Plasmid DNA Vaccines
• Synthetic DNA Vaccines
• 6.8. Global Edible Vaccine Market, Sub-Segmentation Of Live Attenuated Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Live Attenuated Viral Vaccines
• Live Attenuated Bacterial Vaccines
• 6.9. Global Edible Vaccine Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Virus-Like Particle (VLP) Vaccines
• mRNA Vaccines

7. Edible Vaccine Market Regional And Country Analysis

• 7.1. Global Edible Vaccine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Edible Vaccine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Edible Vaccine Market

• 8.1. Asia-Pacific Edible Vaccine Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Edible Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Edible Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Edible Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Edible Vaccine Market

• 9.1. China Edible Vaccine Market Overview
• 9.2. China Edible Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Edible Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Edible Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Edible Vaccine Market

• 10.1. India Edible Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Edible Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Edible Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Edible Vaccine Market

• 11.1. Japan Edible Vaccine Market Overview
• 11.2. Japan Edible Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Edible Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Edible Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Edible Vaccine Market

• 12.1. Australia Edible Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Edible Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Edible Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Edible Vaccine Market

• 13.1. Indonesia Edible Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Edible Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Edible Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Edible Vaccine Market

• 14.1. South Korea Edible Vaccine Market Overview
• 14.2. South Korea Edible Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Edible Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Edible Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Edible Vaccine Market

• 15.1. Western Europe Edible Vaccine Market Overview
• 15.2. Western Europe Edible Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Edible Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Edible Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Edible Vaccine Market

• 16.1. UK Edible Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Edible Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Edible Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Edible Vaccine Market

• 17.1. Germany Edible Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Edible Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Edible Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Edible Vaccine Market

• 18.1. France Edible Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Edible Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Edible Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Edible Vaccine Market

• 19.1. Italy Edible Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Edible Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Edible Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Edible Vaccine Market

• 20.1. Spain Edible Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Edible Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Edible Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Edible Vaccine Market

• 21.1. Eastern Europe Edible Vaccine Market Overview
• 21.2. Eastern Europe Edible Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Edible Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Edible Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Edible Vaccine Market

• 22.1. Russia Edible Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Edible Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Edible Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Edible Vaccine Market

• 23.1. North America Edible Vaccine Market Overview
• 23.2. North America Edible Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Edible Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Edible Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Edible Vaccine Market

• 24.1. USA Edible Vaccine Market Overview
• 24.2. USA Edible Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Edible Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Edible Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Edible Vaccine Market

• 25.1. Canada Edible Vaccine Market Overview
• 25.2. Canada Edible Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Edible Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Edible Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Edible Vaccine Market

• 26.1. South America Edible Vaccine Market Overview
• 26.2. South America Edible Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Edible Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Edible Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Edible Vaccine Market

• 27.1. Brazil Edible Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Edible Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Edible Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Edible Vaccine Market

• 28.1. Middle East Edible Vaccine Market Overview
• 28.2. Middle East Edible Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Edible Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Edible Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Edible Vaccine Market

• 29.1. Africa Edible Vaccine Market Overview
• 29.2. Africa Edible Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Edible Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Edible Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Edible Vaccine Market Competitive Landscape And Company Profiles

• 30.1. Edible Vaccine Market Competitive Landscape
• 30.2. Edible Vaccine Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. GSK plc Overview, Products and Services, Strategy and Financial Analysis

31. Edible Vaccine Market Other Major And Innovative Companies

• 31.1. C.H. Boehringer Sohn AG & Co. KG
• 31.2. Novavax Inc.
• 31.3. Ceva Sante Animale
• 31.4. Sinovac Biotech Ltd.
• 31.5. Hualan Biological Engineering Inc.
• 31.6. Zydus Lifesciences Limited
• 31.7. Bharat Biotech International Limited
• 31.8. Medicago Inc.
• 31.9. CureVac N.V.
• 31.10. Profectus BioSciences Inc.
• 31.11. Vaxart Inc.
• 31.12. China National Biotec Group Company Limited
• 31.13. Vaxine Pty Ltd.
• 31.14. Vaxiion Therapeutics Inc.
• 31.15. Therapix Biosciences Ltd.

32. Global Edible Vaccine Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Edible Vaccine Market

34. Recent Developments In The Edible Vaccine Market

35. Edible Vaccine Market High Potential Countries, Segments and Strategies

• 35.1 Edible Vaccine Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Edible Vaccine Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Edible Vaccine Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer